LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Search

BioNTech SE ADR

Deschisă

Sector Sănătate

117.57 -0.42

Rezumat

Modificarea prețului

24h

Curent

Minim

116.26

Maxim

118.69

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+9.16 upside

Dividende

By Dow Jones

Următoarele câștiguri

4 nov. 2024

Sentimentul știrilor

By Acuity

41%

59%

146 / 366 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

BioNTech SE ADR Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 mai 2024, 11:27 UTC

Câștiguri

BioNTech Swings to Net Loss on Lower Covid Vaccine Sales

20 mar. 2024, 10:44 UTC

Câștiguri

BioNTech Profit Slumps on Lower Covid Vaccine Sales

8 feb. 2024, 11:43 UTC

Achiziții, Fuziuni, Preluări

BioNTech Agrees To Invest $200 Million in Autolus, Starts Strategic Collaboration

5 aug. 2024, 10:02 UTC

Câștiguri

BioNTech Sees 2024 R&D Expenses EUR2.4B-EUR2.6B >BNTX

5 aug. 2024, 10:01 UTC

Câștiguri

BioNTech Backs 2024 View of Rev EUR2.5B-EUR3.1B >BNTX

5 aug. 2024, 10:01 UTC

Câștiguri

BioNTech: Invested EUR525.6M, or About 90% of 2Q R&D Spend, in Non-Covid-19 Related Activities >BNTX

5 aug. 2024, 10:00 UTC

Câștiguri

BioNTech 2Q-End Cash, Equivalents, Security Investments EUR18.5 Billion >BNTX

5 aug. 2024, 09:59 UTC

Câștiguri

BioNTech 2Q Loss EUR807.8M >BNTX

5 aug. 2024, 09:59 UTC

Câștiguri

BioNTech 2Q Loss/Shr EUR3.36 >BNTX

5 aug. 2024, 09:59 UTC

Câștiguri

BioNTech 2Q Rev EUR128.7M >BNTX

6 mai 2024, 20:15 UTC

Câștiguri

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come -- IBD

6 mai 2024, 10:47 UTC

Câștiguri

BioNTech Sees FY24 Rev EUR2.5B-EUR3.1B >BNTX

6 mai 2024, 10:46 UTC

Câștiguri

Correct: BioNTech 1Q Loss/Shr EUR1.31 >BNTX

6 mai 2024, 10:46 UTC

Câștiguri

Correct: BioNTech 1Q Loss EUR315.1M >BNTX

6 mai 2024, 10:46 UTC

Câștiguri

Correct: BioNTech 1Q Rev EUR187.6M >BNTX

6 mai 2024, 10:45 UTC

Câștiguri

BioNTech 1Q Rev $187.6M >BNTX

6 mai 2024, 10:45 UTC

Câștiguri

BioNTech 1Q Loss $315.1M >BNTX

6 mai 2024, 10:45 UTC

Câștiguri

BioNTech 1Q Loss/Shr $1.31 >BNTX

26 mar. 2024, 05:00 UTC

Câștiguri

This Vaccine Maker Sits on Cash Almost Equal to Its Market Value -- Barrons.com

20 mar. 2024, 11:44 UTC

Câștiguri

BioNTech Earnings Fall Short of Estimates. The Stock Is Down. -- Barrons.com

20 mar. 2024, 10:27 UTC

Câștiguri

BioNTech's Stock Sinks After Earnings Fall Below Expectations, Hurt By Writedowns Of Vaccine Inventory -- MarketWatch

20 mar. 2024, 10:17 UTC

Câștiguri

BioNTech 4Q Rev EUR1.48B >BNTX

20 mar. 2024, 10:15 UTC

Câștiguri

Biontech 4Q Net Pft EUR457.9M

20 mar. 2024, 10:15 UTC

Câștiguri

Biontech Plans For Ten or More Registrational Oncology Trials By End of 2024

20 mar. 2024, 10:15 UTC

Câștiguri

Biontech: Annemarie Hanekamp appointed to Management Board as Chief Commercial Officer, effective Jul. 1

20 mar. 2024, 10:15 UTC

Câștiguri

Biontech Aims For First Oncology Launch in 2026 and Ten Indication Approvals by 2030

20 mar. 2024, 10:15 UTC

Câștiguri

Biontech 2023 Gross Profit For COVID-19 Vaccine Business EUR3.2B

20 mar. 2024, 10:15 UTC

Câștiguri

Biontech Sees 2024 Revenue Between EUR2.5B - EUR3.1B

20 mar. 2024, 10:15 UTC

Câștiguri

Biontech 4Q Rev EUR1.48B

8 feb. 2024, 11:28 UTC

Achiziții, Fuziuni, Preluări

BioNTech Agrees To Invest $200 Mln in Autolus, Starts Strategic Collaboration

Comparație

Modificare preț

BioNTech SE ADR Așteptări

Obiectiv de preț

By TipRanks

9.16% sus

Prognoză pe 12 luni

Medie 131.15 USD  9.16%

Maxim 171 USD

Minim 85 USD

În baza a 15 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruBioNTech SE ADR - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

15 ratings

9

Cumpărare

6

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

119.93 / 120.76Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

146 / 366 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie